Acta Neuropathologica CommunicationsNeurosciencePeer-reviewed journal article
In vivo RyR1 reduction in muscle triggers a core-like myopathy
Laurent PelletieriD, Anne PetiotiD, Julie BrocardiD, Benoı̂t Giannesini, Diane GiovanniniiD, Colline Sanchez, Lauriane TravardiD, Mathilde ChivetiD, Mathilde BeaufilsiD, Candice KutchukianiD, David BendahaniD, Daniel METZGERiD, Clara Franzini Armstrong, Norma Beatriz RomeroiD, John RenduiD, Vincent JacquemondiD, Julien FauréiD, Isabelle MartyiD
Abstract
Some mutations in the RYR1 gene lead to congenital myopathies, through reduction in this calcium channel expression level, but the functional whole organism consequences of reduction in RyR1 amount have never been studied. We have developed and characterized a mouse model with inducible muscle specific RYR1 deletion. Recombination in the RYR1 gene resulted in a progressive reduction in the protein amount and was associated with a progressive muscle weakness and atrophy. Calcium fluxes in isolated muscle fibers were accordingly reduced. Alterations in the muscle structure were observed, with fibers atrophy, abnormal mitochondria distribution, membrane remodeling, associated with increase in the expression level of many proteins and inhibition of the autophagy process. This model demonstrates that RyR1 reduction is sufficient to recapitulate most features of Central Core Disease, and accordingly similar alterations were observed in muscle biopsies from Central Core Disease patients, pointing to common pathophysiological mechanisms related to RyR1 reduction.
- organism: mouse
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 23
- FWCI
- 0.57
- Field percentile
- top 40%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional benefit of CRISPR/Cas9-induced allele deletion for RYR1 dominant mutation
Mathilde Beaufils, Margaux Melka, … Isabelle Marty·Molecular Therapy — Nucleic AcidsPeer-reviewed·Jun 17, 2024
- Ryanodine receptor 1 ( RYR1 ) patient-derived muscle cells recapitulate disease phenotypes in 2D and 3D culture models
Joshua S. Clayton, Jordan Crane, … Rhonda L. Taylor·bioRxiv·Jun 20, 2026
- Quantitative proteomic analysis of skeletal muscles from wild type and transgenic mice carrying recessive Ryr1 mutations linked to congenital myopathies
J. Eckhardt, A. Ruiz, … F. Zorzato·bioRxiv·Sep 26, 2022
- Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors
A. Ruiz, S. Benucci, … F. Zorzato·bioRxiv·Nov 9, 2021
- Drosophila ryanodine receptor gene triggers functional and developmental muscle properties and could be used to assess the impact of human RYR1 mutations
Monika Zmojdzian, Teresa Jagla, … Catherine Sarret·eLifePeer-reviewed·May 13, 2026
- Massive reduction of RyR1 in muscle spindles of mice carrying recessive Ryr1 mutations alters proprioception and causes scoliosis
Alexis Ruiz, Sofia Benucci, … Francesco Zorzato·The Journal of PhysiologyPeer-reviewed·Oct 15, 2025